Back to search
FDAFDA · Food and drugs·Recall number D-1129-2018

Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.

Published September 5, 2018 · Recall initiated: August 21, 2018

Summary

FDA records drug Class III recall D-1129-2018, published September 5, 2018 and initiated August 21, 2018. Recalling firm: Mayne Pharma Inc; Status: Terminated; Reported quantity: 6456 bottles; Lot: Lot: FG01517, Exp. 12/31/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mayne Pharma Inc
Distributor
Nationwide in the USA.
Lot
Lot: FG01517, Exp. 12/31/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01. recalled?

Yes. FDA published recall D-1129-2018 on September 5, 2018. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.

What should I do if I have this product?

Voluntary: Firm initiated · Letter